nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC6A3—attention deficit hyperactivity disorder	0.245	0.326	CbGaD
Desipramine—SLC6A4—attention deficit hyperactivity disorder	0.183	0.244	CbGaD
Desipramine—DRD2—attention deficit hyperactivity disorder	0.182	0.243	CbGaD
Desipramine—HTR2A—attention deficit hyperactivity disorder	0.141	0.187	CbGaD
Desipramine—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.00605	0.0802	CbGeAlD
Desipramine—ORM1—saliva—attention deficit hyperactivity disorder	0.00419	0.0555	CbGeAlD
Desipramine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00364	0.0482	CbGeAlD
Desipramine—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.00321	0.0426	CbGeAlD
Desipramine—SMPD1—forebrain—attention deficit hyperactivity disorder	0.00204	0.027	CbGeAlD
Desipramine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00193	0.0256	CbGeAlD
Desipramine—SMPD1—cardiovascular system—attention deficit hyperactivity disorder	0.00172	0.0229	CbGeAlD
Desipramine—SMPD1—nervous system—attention deficit hyperactivity disorder	0.00111	0.0147	CbGeAlD
Desipramine—SMPD1—central nervous system—attention deficit hyperactivity disorder	0.00107	0.0141	CbGeAlD
Desipramine—SMPD1—cerebellum—attention deficit hyperactivity disorder	0.00104	0.0138	CbGeAlD
Desipramine—CHRM4—nervous system—attention deficit hyperactivity disorder	0.000942	0.0125	CbGeAlD
Desipramine—CHRM2—forebrain—attention deficit hyperactivity disorder	0.000931	0.0123	CbGeAlD
Desipramine—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.000928	0.0123	CbGeAlD
Desipramine—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.000915	0.0121	CbGeAlD
Desipramine—CHRM4—central nervous system—attention deficit hyperactivity disorder	0.000907	0.012	CbGeAlD
Desipramine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000897	0.0119	CbGeAlD
Desipramine—ADRB1—forebrain—attention deficit hyperactivity disorder	0.000881	0.0117	CbGeAlD
Desipramine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.000851	0.0113	CbGeAlD
Desipramine—CHRM1—forebrain—attention deficit hyperactivity disorder	0.000847	0.0112	CbGeAlD
Desipramine—SMPD1—brain—attention deficit hyperactivity disorder	0.000846	0.0112	CbGeAlD
Desipramine—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.000787	0.0104	CbGeAlD
Desipramine—CHRM3—forebrain—attention deficit hyperactivity disorder	0.000758	0.0101	CbGeAlD
Desipramine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.000755	0.01	CbGeAlD
Desipramine—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.000749	0.00993	CbGeAlD
Desipramine—ADRB1—cardiovascular system—attention deficit hyperactivity disorder	0.000745	0.00987	CbGeAlD
Desipramine—CHRM5—nervous system—attention deficit hyperactivity disorder	0.000736	0.00976	CbGeAlD
Desipramine—CHRM4—brain—attention deficit hyperactivity disorder	0.00072	0.00955	CbGeAlD
Desipramine—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.000717	0.0095	CbGeAlD
Desipramine—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.000709	0.0094	CbGeAlD
Desipramine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000682	0.00905	CbGeAlD
Desipramine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000639	0.00847	CbGeAlD
Desipramine—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.000613	0.00813	CbGeAlD
Desipramine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000593	0.00786	CbGeAlD
Desipramine—CHRM5—brain—attention deficit hyperactivity disorder	0.000563	0.00746	CbGeAlD
Desipramine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000562	0.00745	CbGeAlD
Desipramine—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.00056	0.00742	CbGeAlD
Desipramine—ORM1—nervous system—attention deficit hyperactivity disorder	0.000542	0.00719	CbGeAlD
Desipramine—HRH1—forebrain—attention deficit hyperactivity disorder	0.000539	0.00715	CbGeAlD
Desipramine—ORM1—central nervous system—attention deficit hyperactivity disorder	0.000522	0.00692	CbGeAlD
Desipramine—CHRM2—nervous system—attention deficit hyperactivity disorder	0.000505	0.0067	CbGeAlD
Desipramine—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.000504	0.00668	CbGeAlD
Desipramine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000499	0.00661	CbGeAlD
Desipramine—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000496	0.00658	CbGeAlD
Desipramine—SLC22A4—cerebellum—attention deficit hyperactivity disorder	0.000491	0.00651	CbGeAlD
Desipramine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000487	0.00646	CbGeAlD
Desipramine—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.000487	0.00645	CbGeAlD
Desipramine—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.000485	0.00643	CbGeAlD
Desipramine—ADRB1—nervous system—attention deficit hyperactivity disorder	0.000478	0.00634	CbGeAlD
Desipramine—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000478	0.00634	CbGeAlD
Desipramine—SLC22A3—nervous system—attention deficit hyperactivity disorder	0.000474	0.00629	CbGeAlD
Desipramine—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.000474	0.00629	CbGeAlD
Desipramine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000469	0.00622	CbGeAlD
Desipramine—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000467	0.00619	CbGeAlD
Desipramine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000462	0.00612	CbGeAlD
Desipramine—ADRB1—central nervous system—attention deficit hyperactivity disorder	0.00046	0.0061	CbGeAlD
Desipramine—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00046	0.0061	CbGeAlD
Desipramine—SLC22A3—central nervous system—attention deficit hyperactivity disorder	0.000457	0.00606	CbGeAlD
Desipramine—CYP2A6—brain—attention deficit hyperactivity disorder	0.000455	0.00603	CbGeAlD
Desipramine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000451	0.00598	CbGeAlD
Desipramine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.00045	0.00597	CbGeAlD
Desipramine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000445	0.0059	CbGeAlD
Desipramine—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.000443	0.00587	CbGeAlD
Desipramine—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000438	0.00581	CbGeAlD
Desipramine—SLC22A5—midbrain—attention deficit hyperactivity disorder	0.00042	0.00557	CbGeAlD
Desipramine—CHRM3—nervous system—attention deficit hyperactivity disorder	0.000412	0.00546	CbGeAlD
Desipramine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00041	0.00544	CbGeAlD
Desipramine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.00041	0.00544	CbGeAlD
Desipramine—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000407	0.00539	CbGeAlD
Desipramine—SLC22A4—brain—attention deficit hyperactivity disorder	0.000399	0.00528	CbGeAlD
Desipramine—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.000396	0.00526	CbGeAlD
Desipramine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000395	0.00524	CbGeAlD
Desipramine—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000391	0.00519	CbGeAlD
Desipramine—CHRM2—brain—attention deficit hyperactivity disorder	0.000386	0.00512	CbGeAlD
Desipramine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000386	0.00512	CbGeAlD
Desipramine—SLC6A3—brain—attention deficit hyperactivity disorder	0.000385	0.00511	CbGeAlD
Desipramine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000381	0.00505	CbGeAlD
Desipramine—SLC22A1—brain—attention deficit hyperactivity disorder	0.000379	0.00503	CbGeAlD
Desipramine—HTR2C—brain—attention deficit hyperactivity disorder	0.000372	0.00494	CbGeAlD
Desipramine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000371	0.00491	CbGeAlD
Desipramine—ADRB1—brain—attention deficit hyperactivity disorder	0.000365	0.00485	CbGeAlD
Desipramine—SLC22A3—brain—attention deficit hyperactivity disorder	0.000363	0.00481	CbGeAlD
Desipramine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000357	0.00473	CbGeAlD
Desipramine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000353	0.00468	CbGeAlD
Desipramine—Mianserin—ADRA2C—attention deficit hyperactivity disorder	0.000353	0.044	CrCbGaD
Desipramine—CHRM1—brain—attention deficit hyperactivity disorder	0.000352	0.00466	CbGeAlD
Desipramine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000349	0.00462	CbGeAlD
Desipramine—SLC22A5—cerebellum—attention deficit hyperactivity disorder	0.000325	0.00431	CbGeAlD
Desipramine—CHRM3—brain—attention deficit hyperactivity disorder	0.000315	0.00417	CbGeAlD
Desipramine—HTR1A—brain—attention deficit hyperactivity disorder	0.000313	0.00416	CbGeAlD
Desipramine—SLC6A2—brain—attention deficit hyperactivity disorder	0.000311	0.00412	CbGeAlD
Desipramine—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.0003	0.00397	CbGeAlD
Desipramine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000297	0.00394	CbGeAlD
Desipramine—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000295	0.00391	CbGeAlD
Desipramine—HRH1—nervous system—attention deficit hyperactivity disorder	0.000293	0.00388	CbGeAlD
Desipramine—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000288	0.00382	CbGeAlD
Desipramine—DRD2—brain—attention deficit hyperactivity disorder	0.000283	0.00376	CbGeAlD
Desipramine—Doxepin—ADRA2C—attention deficit hyperactivity disorder	0.000283	0.0353	CrCbGaD
Desipramine—HRH1—central nervous system—attention deficit hyperactivity disorder	0.000282	0.00374	CbGeAlD
Desipramine—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000281	0.00373	CbGeAlD
Desipramine—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000271	0.00359	CbGeAlD
Desipramine—Protriptyline—SLC6A4—attention deficit hyperactivity disorder	0.000268	0.0334	CrCbGaD
Desipramine—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000265	0.00351	CbGeAlD
Desipramine—SLC22A5—brain—attention deficit hyperactivity disorder	0.000264	0.0035	CbGeAlD
Desipramine—Epinastine—ADRA2A—attention deficit hyperactivity disorder	0.00026	0.0324	CrCbGaD
Desipramine—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000249	0.00331	CbGeAlD
Desipramine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000244	0.00324	CbGeAlD
Desipramine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000235	0.00312	CbGeAlD
Desipramine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.000235	0.0293	CrCbGaD
Desipramine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.00023	0.00305	CbGeAlD
Desipramine—CYP2B6—brain—attention deficit hyperactivity disorder	0.000229	0.00304	CbGeAlD
Desipramine—Maprotiline—SLC6A3—attention deficit hyperactivity disorder	0.000229	0.0285	CrCbGaD
Desipramine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000226	0.003	CbGeAlD
Desipramine—HRH1—brain—attention deficit hyperactivity disorder	0.000224	0.00297	CbGeAlD
Desipramine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000223	0.00295	CbGeAlD
Desipramine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000218	0.00289	CbGeAlD
Desipramine—CYP2E1—brain—attention deficit hyperactivity disorder	0.000215	0.00285	CbGeAlD
Desipramine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000214	0.00284	CbGeAlD
Desipramine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.000211	0.0263	CrCbGaD
Desipramine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000209	0.00278	CbGeAlD
Desipramine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.000195	0.0243	CrCbGaD
Desipramine—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000195	0.00258	CbGeAlD
Desipramine—HTR2A—brain—attention deficit hyperactivity disorder	0.000187	0.00248	CbGeAlD
Desipramine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.000183	0.0227	CrCbGaD
Desipramine—Atomoxetine—HTR1B—attention deficit hyperactivity disorder	0.000174	0.0217	CrCbGaD
Desipramine—CYP2D6—brain—attention deficit hyperactivity disorder	0.00017	0.00226	CbGeAlD
Desipramine—Maprotiline—DRD2—attention deficit hyperactivity disorder	0.00017	0.0212	CrCbGaD
Desipramine—Mianserin—DRD3—attention deficit hyperactivity disorder	0.000165	0.0206	CrCbGaD
Desipramine—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00016	0.00212	CbGeAlD
Desipramine—Atomoxetine—SLC6A3—attention deficit hyperactivity disorder	0.000157	0.0196	CrCbGaD
Desipramine—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000154	0.00204	CbGeAlD
Desipramine—Mianserin—SLC6A3—attention deficit hyperactivity disorder	0.000154	0.0191	CrCbGaD
Desipramine—Epinastine—HTR2A—attention deficit hyperactivity disorder	0.000153	0.019	CrCbGaD
Desipramine—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000151	0.002	CbGeAlD
Desipramine—Mianserin—ADRA2A—attention deficit hyperactivity disorder	0.000151	0.0188	CrCbGaD
Desipramine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.000149	0.0185	CrCbGaD
Desipramine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.000138	0.0172	CrCbGaD
Desipramine—Acepromazine—DRD2—attention deficit hyperactivity disorder	0.000137	0.0171	CrCbGaD
Desipramine—Promazine—DRD4—attention deficit hyperactivity disorder	0.000136	0.017	CrCbGaD
Desipramine—Maprotiline—HTR2A—attention deficit hyperactivity disorder	0.000131	0.0164	CrCbGaD
Desipramine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.000129	0.0161	CrCbGaD
Desipramine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.000127	0.0158	CrCbGaD
Desipramine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.000126	0.0157	CrCbGaD
Desipramine—ABCB1—brain—attention deficit hyperactivity disorder	0.000122	0.00162	CbGeAlD
Desipramine—Doxepin—ADRA2A—attention deficit hyperactivity disorder	0.000121	0.015	CrCbGaD
Desipramine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	0.00012	0.015	CrCbGaD
Desipramine—Atomoxetine—SLC6A4—attention deficit hyperactivity disorder	0.000118	0.0146	CrCbGaD
Desipramine—Promazine—DRD1—attention deficit hyperactivity disorder	0.000116	0.0144	CrCbGaD
Desipramine—Mianserin—SLC6A4—attention deficit hyperactivity disorder	0.000115	0.0143	CrCbGaD
Desipramine—Mianserin—DRD2—attention deficit hyperactivity disorder	0.000114	0.0142	CrCbGaD
Desipramine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.000107	0.0134	CrCbGaD
Desipramine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	0.000106	0.0132	CrCbGaD
Desipramine—Amitriptyline—HTR1B—attention deficit hyperactivity disorder	0.000105	0.0131	CrCbGaD
Desipramine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	0.000105	0.0131	CrCbGaD
Desipramine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	0.000104	0.0129	CrCbGaD
Desipramine—Nortriptyline—SLC6A4—attention deficit hyperactivity disorder	0.000103	0.0128	CrCbGaD
Desipramine—Amitriptyline—DRD3—attention deficit hyperactivity disorder	0.000102	0.0128	CrCbGaD
Desipramine—Nortriptyline—DRD2—attention deficit hyperactivity disorder	0.000102	0.0127	CrCbGaD
Desipramine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	0.000102	0.0127	CrCbGaD
Desipramine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	9.67e-05	0.012	CrCbGaD
Desipramine—Trimipramine—DRD2—attention deficit hyperactivity disorder	9.61e-05	0.012	CrCbGaD
Desipramine—Imipramine—SLC6A3—attention deficit hyperactivity disorder	9.59e-05	0.0119	CrCbGaD
Desipramine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	9.45e-05	0.0118	CrCbGaD
Desipramine—Amitriptyline—ADRA2A—attention deficit hyperactivity disorder	9.34e-05	0.0116	CrCbGaD
Desipramine—Promethazine—DRD2—attention deficit hyperactivity disorder	9.26e-05	0.0115	CrCbGaD
Desipramine—Doxepin—SLC6A4—attention deficit hyperactivity disorder	9.21e-05	0.0115	CrCbGaD
Desipramine—Doxepin—DRD2—attention deficit hyperactivity disorder	9.16e-05	0.0114	CrCbGaD
Desipramine—Atomoxetine—HTR2A—attention deficit hyperactivity disorder	9.03e-05	0.0113	CrCbGaD
Desipramine—Mianserin—HTR2A—attention deficit hyperactivity disorder	8.83e-05	0.011	CrCbGaD
Desipramine—Promazine—DRD2—attention deficit hyperactivity disorder	8.14e-05	0.0101	CrCbGaD
Desipramine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	8.07e-05	0.0101	CrCbGaD
Desipramine—Nortriptyline—HTR2A—attention deficit hyperactivity disorder	7.89e-05	0.00983	CrCbGaD
Desipramine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	7.43e-05	0.00926	CrCbGaD
Desipramine—Imipramine—SLC6A4—attention deficit hyperactivity disorder	7.17e-05	0.00893	CrCbGaD
Desipramine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	7.17e-05	0.00893	CrCbGaD
Desipramine—Promethazine—HTR2A—attention deficit hyperactivity disorder	7.15e-05	0.00891	CrCbGaD
Desipramine—Imipramine—DRD2—attention deficit hyperactivity disorder	7.13e-05	0.00888	CrCbGaD
Desipramine—Amitriptyline—SLC6A4—attention deficit hyperactivity disorder	7.12e-05	0.00888	CrCbGaD
Desipramine—Amitriptyline—DRD2—attention deficit hyperactivity disorder	7.09e-05	0.00883	CrCbGaD
Desipramine—Doxepin—HTR2A—attention deficit hyperactivity disorder	7.08e-05	0.00882	CrCbGaD
Desipramine—Promazine—HTR2A—attention deficit hyperactivity disorder	6.29e-05	0.00784	CrCbGaD
Desipramine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	5.54e-05	0.0069	CrCbGaD
Desipramine—Imipramine—HTR2A—attention deficit hyperactivity disorder	5.51e-05	0.00686	CrCbGaD
Desipramine—Amitriptyline—HTR2A—attention deficit hyperactivity disorder	5.48e-05	0.00682	CrCbGaD
Desipramine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.65e-05	9.97e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.65e-05	9.95e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.65e-05	9.94e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.64e-05	9.93e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.64e-05	9.93e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.64e-05	9.91e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.64e-05	9.91e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.64e-05	9.88e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.63e-05	9.84e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.63e-05	9.82e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.62e-05	9.81e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.62e-05	9.79e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.62e-05	9.78e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.62e-05	9.78e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.62e-05	9.78e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.62e-05	9.77e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.62e-05	9.76e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.61e-05	9.74e-05	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—COMT—attention deficit hyperactivity disorder	1.61e-05	9.72e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.6e-05	9.66e-05	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—MAOA—attention deficit hyperactivity disorder	1.6e-05	9.65e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.59e-05	9.62e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.57e-05	9.47e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.56e-05	9.4e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.52e-05	9.21e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	1.52e-05	9.17e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.52e-05	9.17e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.52e-05	9.17e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.51e-05	9.15e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.51e-05	9.12e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.51e-05	9.12e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.5e-05	9.09e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.5e-05	9.08e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.5e-05	9.07e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	1.49e-05	9.02e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.49e-05	9.01e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.49e-05	9e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.48e-05	8.94e-05	CbGpPWpGaD
Desipramine—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	1.47e-05	8.85e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.46e-05	8.83e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.46e-05	8.81e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.45e-05	8.76e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.45e-05	8.74e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.44e-05	8.68e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.43e-05	8.64e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.42e-05	8.58e-05	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.42e-05	8.56e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.41e-05	8.52e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.4e-05	8.46e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.4e-05	8.43e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.39e-05	8.39e-05	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.39e-05	8.37e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.38e-05	8.32e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.36e-05	8.21e-05	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.36e-05	8.19e-05	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.35e-05	8.14e-05	CbGpPWpGaD
Desipramine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	1.35e-05	8.13e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.34e-05	8.11e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.33e-05	8.05e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.32e-05	7.99e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.32e-05	7.95e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.31e-05	7.94e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.31e-05	7.89e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.31e-05	7.89e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.3e-05	7.87e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.29e-05	7.82e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.29e-05	7.77e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.29e-05	7.76e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.28e-05	7.73e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.28e-05	7.73e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.28e-05	7.73e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.27e-05	7.7e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.27e-05	7.66e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.27e-05	7.65e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.26e-05	7.61e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.26e-05	7.6e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.26e-05	7.6e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.26e-05	7.59e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.25e-05	7.57e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.25e-05	7.56e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.25e-05	7.54e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.24e-05	7.48e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.24e-05	7.47e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.23e-05	7.44e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.23e-05	7.43e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.22e-05	7.39e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.21e-05	7.33e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.21e-05	7.32e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.2e-05	7.25e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.19e-05	7.22e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.19e-05	7.19e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.18e-05	7.16e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.18e-05	7.12e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.18e-05	7.12e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.17e-05	7.09e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.17e-05	7.07e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.17e-05	7.06e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.16e-05	7.04e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.16e-05	7.03e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.16e-05	7.01e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.16e-05	6.98e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.15e-05	6.97e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.15e-05	6.94e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.15e-05	6.93e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.14e-05	6.9e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.14e-05	6.88e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.13e-05	6.81e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	6.78e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.12e-05	6.76e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.11e-05	6.73e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.11e-05	6.73e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.11e-05	6.7e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.1e-05	6.65e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.1e-05	6.64e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.1e-05	6.62e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.09e-05	6.59e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.09e-05	6.55e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.08e-05	6.53e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.08e-05	6.53e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—COMT—attention deficit hyperactivity disorder	1.07e-05	6.45e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.06e-05	6.41e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.06e-05	6.41e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.06e-05	6.41e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.06e-05	6.39e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.05e-05	6.37e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.04e-05	6.31e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.04e-05	6.3e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.04e-05	6.28e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.04e-05	6.27e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.03e-05	6.24e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.02e-05	6.18e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.02e-05	6.18e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.02e-05	6.17e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.02e-05	6.15e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.01e-05	6.13e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.01e-05	6.09e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.01e-05	6.07e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	9.96e-06	6.02e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.94e-06	6e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.91e-06	5.99e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.9e-06	5.98e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.89e-06	5.98e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.89e-06	5.97e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	9.87e-06	5.96e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.87e-06	5.96e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.86e-06	5.96e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.83e-06	5.94e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	9.81e-06	5.92e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.78e-06	5.91e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.75e-06	5.89e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.74e-06	5.88e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.74e-06	5.88e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.73e-06	5.88e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.72e-06	5.87e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	9.71e-06	5.87e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.69e-06	5.86e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.66e-06	5.84e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	9.63e-06	5.82e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.63e-06	5.82e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.63e-06	5.81e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.6e-06	5.8e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.57e-06	5.78e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.57e-06	5.78e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.54e-06	5.76e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	9.48e-06	5.73e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.45e-06	5.71e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.26e-06	5.6e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	9.2e-06	5.56e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	9.13e-06	5.52e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	9.08e-06	5.48e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	9.08e-06	5.48e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.03e-06	5.45e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.97e-06	5.42e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.95e-06	5.4e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	8.93e-06	5.4e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.92e-06	5.39e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.89e-06	5.37e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	8.87e-06	5.36e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.81e-06	5.32e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.8e-06	5.32e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	8.6e-06	5.19e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	8.3e-06	5.02e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	7.91e-06	4.78e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.89e-06	4.77e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	7.86e-06	4.75e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	7.75e-06	4.68e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.7e-06	4.65e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	7.7e-06	4.65e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	7.69e-06	4.65e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.69e-06	4.65e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.6e-06	4.59e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	7.57e-06	4.57e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.51e-06	4.54e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.43e-06	4.49e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.33e-06	4.43e-05	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—EP300—attention deficit hyperactivity disorder	7.31e-06	4.41e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.27e-06	4.39e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	7.26e-06	4.38e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.23e-06	4.37e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.03e-06	4.25e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	6.91e-06	4.17e-05	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—EP300—attention deficit hyperactivity disorder	6.9e-06	4.17e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.38e-06	3.86e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.27e-06	3.79e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.25e-06	3.77e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.23e-06	3.76e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.17e-06	3.72e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.15e-06	3.71e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	5.98e-06	3.61e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	5.94e-06	3.59e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	5.94e-06	3.59e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.94e-06	3.59e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.85e-06	3.54e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	5.84e-06	3.53e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	5.84e-06	3.53e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	5.8e-06	3.5e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.76e-06	3.48e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	5.5e-06	3.32e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	5.46e-06	3.3e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.43e-06	3.28e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.91e-06	2.96e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.75e-06	2.87e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.7e-06	2.84e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	4.66e-06	2.81e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	4.63e-06	2.79e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—EP300—attention deficit hyperactivity disorder	4.58e-06	2.77e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.52e-06	2.73e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.49e-06	2.71e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	4.27e-06	2.58e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	4.21e-06	2.54e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.03e-06	2.43e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	3.95e-06	2.38e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.94e-06	2.38e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.85e-06	2.33e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.83e-06	2.31e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	3.6e-06	2.17e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	3.57e-06	2.16e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	3.39e-06	2.05e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.38e-06	2.04e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.33e-06	2.01e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	3.32e-06	2.01e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.32e-06	2.01e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.31e-06	2e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.3e-06	1.99e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.27e-06	1.97e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	2.56e-06	1.55e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	2.5e-06	1.51e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	2.36e-06	1.42e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	2e-06	1.21e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.54e-06	9.32e-06	CbGpPWpGaD
